Drug recall · July 9, 2025
Gabapentin Capsules recall
Why: Defective container; blister packaging inadequately sealed.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Gabapentin Capsules, USP, 100 mg, 100 capsules (10x10), blister pack cartons, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN, 46268 USA, NDC 0904-6665-61
- Lots / codes
Lot# M05205, Exp Date 10/2026
- Quantity
- 23,232 cartons
- Company
- The Harvard Drug Group LLC, Dublin, OH
- Distribution
- Nationwide
- Initiated
- June 19, 2025 · Voluntary: Firm initiated
- Classified
- July 3, 2025
- Reported
- July 9, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Gabapentin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.